These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17729022)

  • 1. Is tiagabine helpful in generalized anxiety disorder?
    Balon R
    Ann Clin Psychiatry; 2007; 19(3):197. PubMed ID: 17729022
    [No Abstract]   [Full Text] [Related]  

  • 2. An open-label study to evaluate switching from an SSRI or SNRI to tiagabine to alleviate antidepressant-induced sexual dysfunction in generalized anxiety disorder.
    Schwartz TL; Nasra GS; Ashton AK; Kang D; Kumaresan H; Chilton M; Bertone F
    Ann Clin Psychiatry; 2007; 19(1):25-30. PubMed ID: 17453658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tiagabine for the treatment of generalized anxiety disorder: a randomized, open-label, clinical trial with paroxetine as a positive control.
    Rosenthal M
    J Clin Psychiatry; 2003 Oct; 64(10):1245-9. PubMed ID: 14658975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Questionable tolerability of tiagabine in generalized anxiety disorder.
    Spielmans GI
    J Clin Psychopharmacol; 2009 Jun; 29(3):314. PubMed ID: 19440099
    [No Abstract]   [Full Text] [Related]  

  • 5. Tiagabine in anxiety disorders.
    Schwartz TL; Nihalani N
    Expert Opin Pharmacother; 2006 Oct; 7(14):1977-87. PubMed ID: 17020423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New perspectives in the management of depression. Symposium highlights from ECNP, Venice, September 1995.
    J Clin Psychiatry; 1996 Aug; 57(8):377-84. PubMed ID: 8752026
    [No Abstract]   [Full Text] [Related]  

  • 7. Tiagabine for social anxiety disorder.
    Dunlop BW; Papp L; Garlow SJ; Weiss PS; Knight BT; Ninan PT
    Hum Psychopharmacol; 2007 Jun; 22(4):241-4. PubMed ID: 17476705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tiagabine in adult patients with generalized anxiety disorder: results from 3 randomized, double-blind, placebo-controlled, parallel-group studies.
    Pollack MH; Tiller J; Xie F; Trivedi MH
    J Clin Psychopharmacol; 2008 Jun; 28(3):308-16. PubMed ID: 18480688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of tiagabine augmentation for treatment-resistant anxiety disorders: a case series.
    Schwartz TL
    Psychopharmacol Bull; 2002; 36(2):53-7. PubMed ID: 12397840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose tiagabine effectiveness in anxiety disorders.
    Schaller JL; Thomas J; Rawlings D
    MedGenMed; 2004 Sep; 6(3):8. PubMed ID: 15520630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venlafaxine XR in the treatment of anxiety.
    Hackett D
    Acta Psychiatr Scand Suppl; 2000; (406):30-5. PubMed ID: 11131468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tiagabine for the treatment of anxiety.
    Crane D
    Depress Anxiety; 2003; 18(1):51-2. PubMed ID: 12900953
    [No Abstract]   [Full Text] [Related]  

  • 13. Mania after venlafaxine withdrawal in a patient with generalized anxiety disorder.
    Khazaal Y
    Ann Pharmacother; 2007 Feb; 41(2):359-60. PubMed ID: 17284507
    [No Abstract]   [Full Text] [Related]  

  • 14. Vigabatrin and tiagabine might have antipanic properties.
    Zwanzger P; Rupprecht R
    J Psychopharmacol; 2004 Sep; 18(3):440. PubMed ID: 15358993
    [No Abstract]   [Full Text] [Related]  

  • 15. An open clinical trial of venlafaxine treatment of fibromyalgia.
    Dwight MM; Arnold LM; O'Brien H; Metzger R; Morris-Park E; Keck PE
    Psychosomatics; 1998; 39(1):14-7. PubMed ID: 9538670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seizures associated with venlafaxine, methylphenidate, and zolpidem.
    Tavakoli SA; Gleason OC
    Psychosomatics; 2003; 44(3):262-4. PubMed ID: 12724513
    [No Abstract]   [Full Text] [Related]  

  • 17. Citalopram-induced hallucinations and delusions in a young adult.
    Capaldi VF; Carr RB
    Gen Hosp Psychiatry; 2010; 32(6):648.e1-3. PubMed ID: 21112465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venlafaxine extended release (XR) in the treatment of generalized anxiety disorder.
    Sheehan DV
    J Clin Psychiatry; 1999; 60 Suppl 22():23-8. PubMed ID: 10634352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vital functions at risk. Dealing with depressions rapidly and comprehensively].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():93. PubMed ID: 15373071
    [No Abstract]   [Full Text] [Related]  

  • 20. A PET study of tiagabine treatment implicates ventral medial prefrontal cortex in generalized social anxiety disorder.
    Evans KC; Simon NM; Dougherty DD; Hoge EA; Worthington JJ; Chow C; Kaufman RE; Gold AL; Fischman AJ; Pollack MH; Rauch SL
    Neuropsychopharmacology; 2009 Jan; 34(2):390-8. PubMed ID: 18536708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.